Shaji S Kumar

389PUBLICATIONS
770CO-AUTHORS
Haematological tumoursModelling and simulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (389)

|Aug 31, 2026
Primary Plasma Cell Leukemia.

|Aug 29, 2026
Subtype specific artificial intelligence modelling of cardiac amyloidosis using echocardiography and electrocardiography.

|Aug 25, 2026
Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma.

|Aug 25, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

|Aug 24, 2026
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

|Jul 27, 2026
Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma.

Pageof 65

Frequent Collaborators

127 joint publications

Angela Dispenzieri

114 joint publications

Morie Gertz

106 joint publications

Vincent S Rajkumar

102 joint publications

Nelson R Leung